Xelaglifam

DB21598InvestigationalSmall molecule

Xelaglifam is a small molecule drug. Xelaglifam is under investigation in clinical trial NCT04982705 (IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics). Xelaglifam has a monoisotopic molecular weight of...

Mechanism: Pharmacologically active on Free fatty acid receptor 1
Curator reviewed
Formula / weight: C₃₀H₂₈FNO₅ · 501.554 g/mol (avg)
Code names: IDG-16177

Resolves to

Compound

UNIIZ45YM6Z5DFCAS2230597-99-4ChEMBLCHEMBL5314448ChEBI759157PubChem135125120

Structure

InChIKeyIJUWQJZOUDTENA-HRRBBWQUSA-NSMILESCC#C[C@@H](CC(O)=O)C1=CC=C(O[C@@H]2CCC3=C2C(F)=CC=C3C2=CC=C(O[C@@H]3CCOC3)N=C2)C=C1

Targets

O14842FFAR1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Xelaglifam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account